RecruitingNot ApplicableNCT07287306

Effects of BLa80 and LRa05 on the Gut Microbiota Metabolite Profile of Healthy Individuals

Effects of BLa80 and LRa05 on the Gut Microbiota Metabolite Profile of Healthy Individuals: A Randomized, Double-Blind, Placebo-Controlled Trial


Sponsor

Wecare Probiotics Co., Ltd.

Enrollment

375 participants

Start Date

Dec 10, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Gut microbiota play a key role in polyphenol metabolism, participating in the breakdown of dietary components and producing various small molecule metabolites that affect human health. However, little is currently known about how gut microbes metabolize dietary compounds and produce bioactive metabolites. This study aims to use metabolomics to precisely identify food-derived metabolites in the blood to investigate whether probiotics (BLa80, LRa05) can enhance the breakdown of dietary components and improve their absorption and utilization in the human body.


Eligibility

Min Age: 18 YearsMax Age: 60 Years

Inclusion Criteria3

  • Male or female participants aged 18 to 60 years;
  • Healthy individuals;
  • Participants must provide written informed consent.

Exclusion Criteria6

  • History of gastrointestinal surgery, other gastrointestinal diseases, metabolic disorders, immunodeficiency, hyperthyroidism, or cardiac or liver disease;
  • Use of immunosuppressants;
  • Pregnant or breastfeeding women;
  • Participants who have taken antibiotics or probiotics within the previous 3 months;
  • Planned surgery during the study period;
  • Patients with neurological disorders or psychiatric illness.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTPlacebo

The experimental phase of this study will last 8 weeks and each subject will receive 3 follow-up visits (week 0, week 4, week 8).

DIETARY_SUPPLEMENTBLa80

The experimental phase of this study will last 8 weeks and each subject will receive 3 follow-up visits (week 0, week 4, week 8).

DIETARY_SUPPLEMENTLRa05

The experimental phase of this study will last 8 weeks and each subject will receive 3 follow-up visits (week 0, week 4, week 8).


Locations(1)

The First Affiliated Hospttal, Sun Yat-sen University

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07287306


Related Trials